Li Ding

机构：Tongji University, Anhui University, Shanghai Jiao Tong University, Chinese Academy of Sciences, Washington University in St. Louis, Renji Hospital, PLA Electronic Engineering Institute, Shanghai Cancer Institute, Technical Institute of Physics and Chemistry · ORCID：0000-0003-3851-5504

发表论文 87 篇 · 总被引 3853 次 · h-index 31

代表论文

• 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases (2021 · Nature Communications · 被引 510)
• A Metal‐Organic Framework (MOF) Fenton Nanoagent‐Enabled Nanocatalytic Cancer Therapy in Synergy with Autophagy Inhibition (2020 · Advanced Materials · 被引 366)
• Ultrathin Molybdenum Carbide MXene with Fast Biodegradability for Highly Efficient Theory‐Oriented Photonic Tumor Hyperthermia (2019 · Advanced Functional Materials · 被引 269)
• Living Macrophage-Delivered Tetrapod PdH Nanoenzyme for Targeted Atherosclerosis Management by ROS Scavenging, Hydrogen Anti-inflammation, and Autophagy Activation (2022 · ACS Nano · 被引 177)
• A Calcium Fluoride Nanozyme for Ultrasound‐Amplified and Ca 2+ ‐Overload‐Enhanced Catalytic Tumor Nanotherapy (2022 · Advanced Materials · 被引 124)
• Measurements of the size and correlations between ions using an electrolytic point contact (2019 · Nature Communications · 被引 68)